Positive Effects of Early Androgen Therapy on the Behavioral Phenotype of Boys with 47,XXY
Overview
Authors
Affiliations
47, XXY occurs in up to 1 in 650 male births and is associated with androgen deficiency, neurodevelopmental delays, and atypical social-behaviors. Previously, we showed that young boys with 47, XXY who received early hormonal therapy (EHT) had significantly improved neurodevelopment. The objective of this follow-up study was to examine the effects of EHT on social behavior in boys with 47, XXY. The study consisted of boys prenatally diagnosed with 47, XXY who were referred for evaluations. Twenty-nine boys received three injections of 25 mg testosterone enanthate and 57 controls did not receive EHT. Behavioral functioning was assessed using the Behavior Rating Inventory of Executive Function, Social Responsiveness Scale, 2nd Ed., and the Child Behavior Checklist for Ages 6-18. The hypothesis that EHT may affect behavior was formulated prior to data collection. Questionnaire data was prospectively obtained and analyzed to test for significance between two groups. Significant differences were identified between group's scores over time in Social Communication (P=0.007), Social Cognition (P=0.006), and Total T-score (P=0.001) on the SRS-2; Initiation (P=0.05) on the BRIEF; and Externalizing Problems (P=0.024), Affective Problems (P=0.05), and Aggressive Behaviors (P=0.031) on the CBCL. This is the third study revealing positive effects of EHT on boys with XXY. There was a significant improvements associated with the 47, XXY genotype in boys who received EHT. Research is underway on the neurobiological mechanisms, and later developmental effects of EHT.
Davis S, Howell S, Janusz J, Lahlou N, Reynolds R, Thompson T medRxiv. 2024; .
PMID: 39711709 PMC: 11661422. DOI: 10.1101/2024.12.09.24318726.
SCAN: a nanopore-based, cost effective decision-supporting tool for mass screening of aneuploidies.
Schack A, Garrido-Navas M, Galevski D, Madjarov G, Krych L Hum Genomics. 2024; 18(1):131.
PMID: 39578906 PMC: 11583562. DOI: 10.1186/s40246-024-00690-w.
Hamzik M, Gropman A, Brooks M, Powell S, Sadeghin T, Samango-Sprouse C Genes (Basel). 2023; 14(7).
PMID: 37510306 PMC: 10379663. DOI: 10.3390/genes14071402.
Yuan X, Yong W, Dai L, Wang W, Wu L Ann Transl Med. 2023; 11(2):111.
PMID: 36819517 PMC: 9929816. DOI: 10.21037/atm-22-6343.
Educational status, testosterone replacement, and intelligence outcomes in Klinefelter syndrome.
Simonetti L, Silva M, Mello C Dement Neuropsychol. 2022; 16(1):97-104.
PMID: 35719264 PMC: 9170263. DOI: 10.1590/1980-5764-DN-2021-0049.